Mycobacterium Citations List: June 2023

Literature Citations

1. Inhibition Studies on Human and Mycobacterial Carbonic Anhydrases with N-((4-Sulfamoylphenyl)carbamothioyl) amides. Abdoli, M., A. Bonardi, N. Paoletti, A. Aspatwar, S. Parkkila, P. Gratteri, C.T. Supuran, and R. Žalubovskis. Molecules, 2023. 28(10): 4020. PMID[37241761]. PMCID[PMC10222120].
[PubMed]. TB_06_2023.

2. Design and Synthesis of Novel Quinazolinyl-bisspirooxindoles as Potent Anti-tubercular Agents: An Ultrasound-promoted Methodology. Allaka, B.S., S. Basavoju, E. Madhu Rekha, D. Sriram, and G. Rama Krishna. Molecular Diversity, 2023. 27(3): p. 1427-1436. PMID[35933454].
[PubMed]. TB_06_2023.

3. Synthesis and in-Vitro Antimycobacterial Evaluation of 4-Arylidene-2-phenyl-6-(aryl)-4,5-dihydropyridazin-3(2H)-one Derivatives. Almehmadi, M.M., A.A. Alsaiari, and M. Asif. Pharmaceutical Chemistry Journal, 2023: p. 265-273. ISI[000987941800002].
[WOS]. TB_06_2023.

4. Experimental Studies of the Liposomal Form of Lytic Mycobacteriophage D29 for the Treatment of Tuberculosis Infection. Avdeev, V.V., V.V. Kuzin, M.A. Vladimirsky, and I.A. Vasilieva. Microorganisms, 2023. 11(5): 1214. PMID[37317188]. PMCID[PMC10221482].
[PubMed]. TB_06_2023.

5. Inoculum-dependent Bactericidal Activity of a Mycobacterium tuberculosis Mmpl3 Inhibitor. Berube, B., A. Deshpande, A. Bhagwat, and T. Parish. Microbiology, 2023. 169(6): 001345. PMID[37334886].
[PubMed]. TB_06_2023.

6. Using Dynamic Oral Dosing of Rifapentine and Rifabutin to Simulate Exposure Profiles of Long-acting Formulations in a Mouse Model of Tuberculosis Preventive Therapy. Chang, Y.S., S.Y. Li, H. Pertinez, F. Betoudji, J. Lee, S.P. Rannard, A. Owen, E.L. Nuermberger, and N.C. Ammerman. Antimicrobial Agents and Chemotherapy, 2023. 2023: e0048123. PMID[37338374].
[PubMed]. TB_06_2023.

7. Synthesis and anti-Mycobacterium tuberculosis Activity of Imidazo[2,1-b][1,3]oxazine Derivatives against Multidrug-resistant Strains. Fernandes, G.F.S., K.F. Manieri, A.F. Bonjorno, D.L. Campos, C.M. Ribeiro, F.M. Demarqui, D.A.G. Ruiz, N.M. Nascimento-Junior, W.A. Denny, A.M. Thompson, F.R. Pavan, and J.L. Dos Santos. ChemMedChem, 2023. 18(12): e202300015. PMID[37002895].
[PubMed]. TB_06_2023.

8. In Vitro Synergistic Effects of Omadacycline with Other Antimicrobial Agents against Mycobacterium abscessus. Fujiwara, K., A. Aono, T. Asami, K. Morimoto, K. Kamada, Y. Morishige, Y. Igarashi, K. Chikamatsu, Y. Murase, H. Yamada, A. Takaki, and S. Mitarai. Antimicrobial Agents and Chemotherapy, 2023. 67(6): e0157922. PMID[37154742]. PMCID[PMC10269086].
[PubMed]. TB_06_2023.

9. Activity of the Old Antimicrobial Nitroxoline against Mycobacterium abscessus Complex Isolates. Hoffmann, A.M., M. Wolke, J. Rybniker, G. Plum, and F. Fuchs. Journal of Global Antimicrobial Resistance, 2023. 33: p. 1-4. PMID[36842457].
[PubMed]. TB_06_2023.

10. Comparison of the Diagnostic Performance of Meltpro and Next-generation Sequencing in Determining Fluoroquinolone Resistance in Multidrug-resistant Tuberculosis Isolates. Hu, Y., Y. Chi, X. Feng, F. Yu, H. Li, Y. Shang, J. Pan, and Y. Pang. The Journal of Molecular Diagnostics, 2023. 25(6): p. 342-351. PMID[37208048].
[PubMed]. TB_06_2023.

11. Omadacycline, Eravacycline, and Tigecycline Express anti-Mycobacterium abscessus Activity in Vitro. Li, A., S. He, J. Li, Z. Zhang, B. Li, and H. Chu. Microbiology Spectrum, 2023. 11(3): e0071823. PMID[37140428]. PMCID[PMC10269442].
[PubMed]. TB_06_2023.

12. QSAR-guided Study for the Microwave-assisted Synthesis of 4-Methylquinoline Derivatives with Antimycobacterial Activity. Luczywo, A., M. Soto, G.C. Muscia, G.P. Romanelli, G. Sathicq, C. Gonzalez, J. Mella, M. Mellado, and S.E. Asis. ChemistrySelect, 2023. 8(20): e202300042. ISI[000992215900001].
[WOS]. TB_06_2023.

13. Investigation into the Mechanism of Action of the Tuberculosis Drug Candidate SQ109 and Its Metabolites and Analogues in Mycobacteria. Malwal, S.R., B. Mazurek, J. Ko, P. Xie, C. Barnes, C. Varvitsiotis, M.D. Zimmerman, S. Olatunji, J. Lee, M. Xie, J. Sarathy, M. Caffrey, N.C.J. Strynadka, V. Dartois, T. Dick, B.N.R. Lee, D.G. Russell, and E. Oldfield. Journal of Medicinal Chemistry, 2023. 66(11): p. 7553-7569. PMID[37235809]. PMCID[PMC10330530].
[PubMed]. TB_06_2023.

14. Caryophyllene sesquiterpenes from a Chaetomium Globosum Endophyte of the Canadian Medicinal Plant Empetrum nigrum. Morehouse, N.J., T.N. Clark, R.G. Kerr, J.A. Johnson, and C.A. Gray. Journal of Natural Products, 2023. 86(6): p. 1615-1619. PMID[37267043].
[PubMed]. TB_06_2023.

15. New Cocrystals of Heterocyclic Drugs: Structural, Antileishmanial, Larvicidal and Urease Inhibition Studies. Murtaza, G., M. Khan, S. Farooq, M.I. Choudhary, and S. Yousuf. Acta Crystallographica Section C: Structural Chemistry, 2023. 79(Pt 6): p. 237-248. PMID[37140892].
[PubMed]. TB_06_2023.

16. Synthesis and Pharmacological Evaluation of 1,3-Diaryl Substituted Pyrazole Based (Thio)urea Derivatives as Potent Antimicrobial Agents against Multi-drug Resistant Staphylococcus aureus and Mycobacterium tuberculosis. Ommi, O., M.N. Ahmad, S.N.R. Gajula, P. Wanjari, S. Sau, P.K. Agnivesh, S.K. Sahoo, N.P. Kalia, R. Sonti, S. Nanduri, A. Dasgupta, S. Chopra, and V.M. Yaddanapudi. RSC Medicinal Chemistry, 2023. ISI[001002263000001].
[WOS]. TB_06_2023.

17. Site-directed Mutagenesis of Mycobacterium tuberculosis and Functional Validation to Investigate Potential Bedaquiline Resistance-causing Mutations. Otum, C.C., E. Rivière, M. Barnard, J. Loubser, M.J. Williams, E.M. Streicher, A. Van Rie, R.M. Warren, and M. Klopper. Scientific Reports, 2023. 13(1): p. 9212. PMID[37280265]. PMCID[PMC10244393].
[PubMed]. TB_06_2023.

18. Antagonist Impact of Selenium-based Nanoparticles against Mycobacterium tuberculosis. Parveen, S., T. Sur, S. Sarkar, and R. Roy. Applied Biochemistry and Biotechnology, 2023. 195(6): p. 3606-3614. PMID[36637700].
[PubMed]. TB_06_2023.

19. Bedaquiline Resistance Pattern in Clofazimine-resistant Clinical Isolates of Tuberculosis Patients. Shang, Y., S. Chen, W. Shi, W. Nie, W. Jing, F. Huo, Y. Xue, L. Dong, G. Jiang, H. Huang, and N. Chu. Journal of Global Antimicrobial Resistance, 2023. 33: p. 294-300. PMID[37142094].
[PubMed]. TB_06_2023.

20. The Lichen-derived Streptomyces Isolated from Pyxine cocoes Produces the Antibiotic with Potent Antimicrobial and Antitumor Activities. Somphong, A., V. Poengsungnoen, K. Buaruang, P. Sripreechasak, K. Khantasup, C. Intaraudom, P. Pittayakhajonwut, S. Tanasupawat, and W. Phongsopitanun. ScienceAsia, 2023. 49(3): p. 328-336. ISI[000995801200001].
[WOS]. TB_06_2023.

21. Characterization of Spectinamide 1599 Efficacy against Different Mycobacterial Phenotypes. Temrikar, Z.H., S. Kodidela, S. Kumar, J. Liu, G.T. Robertson, R.E. Lee, A.J. Hickey, M. Gonzalez-Juarrero, and B. Meibohm. Tuberculosis, 2023. 140: 102342. PMID[37120915]. PMCID[PMC10247484].
[PubMed]. TB_06_2023.

22. Characterization of DNA Gyrase Activity and Elucidation of the Impact of Amino Acid Substitution in Gyra on Fluoroquinolone Resistance in Mycobacterium avium. Thapa, J., J.Y. Chizimu, S. Kitamura, M.L. Akapelwa, P. Suwanthada, N. Miura, J. Toyting, T. Nishimura, N. Hasegawa, Y. Nishiuchi, S.V. Gordon, C. Nakajima, and Y. Suzuki. Microbiology Spectrum, 2023. 11(3): e0508822. PMID[37067420]. PMCID[PMC10269562].
[PubMed]. TB_06_2023.

23. Fragment Merging Using a Graph Database Samples Different Catalogue Space Than Similarity Search. Wills, S., R. Sanchez-Garcia, T. Dudgeon, S.D. Roughley, A. Merritt, R.E. Hubbard, J. Davidson, F. von Delft, and C.M. Deane. Journal of Chemical Information and Modeling, 2023. 63(11): p. 3423-3437. PMID[37229647]. PMCID[PMC10268959].
[PubMed]. TB_06_2023.

24. Synthesis, Characterization, Antitubercular Activity, and Molecular Docking Studies of Pyrazolylpyrazoline-clubbed Triazole and Tetrazole Hybrids. Zala, M., J.J. Vora, and V.M. Khedkar. ACS Omega, 2023. 8(23): p. 20262-20271. PMID[37323386]. PMCID[PMC10268283].
[PubMed]. TB_06_2023.

Patent Citations

This month, no relevant Mycobacterium patents were identified.